The researchers demonstrated that NUDCD3 mutations impede a crucial gene-rearranging mechanism known as V(D)J recombination ...

Achilles Therapeutics has announced it will discontinue its tumor-infiltrating lymphocyte (TIL)-based clonal neoantigen T ...

Vallina, from the CRIS Immuno-Oncology Unit, in Madrid (Spain), explains that a new approach provides 'trained troops' of ...

T cells are our first line of defense against cancer, but the battle tends to exhaust them. Now, scientists have found a way ...

Certain types of tumors make up the majority of that 20%, such as melanoma, non-small cell lung cancer, and certain ...

Employees at Achilles Therapeutics are bracing themselves for job losses after the UK biotech announced that it is dropping ...

Due to the remarkable success of the Research Topic 'New Insights in Veterinary Cancer Immunology' and the rapidly evolving subject area, we are pleased to launch Volume II for this topic. The tumour ...

Positive opinion granted for KEYTRUDA plus chemotherapy for the first-line treatment of adult patients with primary advanced or recurrent endometrial carcinoma who are candidates for systemic therapy, ...

The community in west Cavan is rallying around a popular retired local GP in a bid to help pay for specialist cancer therapy ...

The firm is discontinuing its CHIRON and THETIS trials after lackluster data and is planning for potential third-party deals and workforce layoffs.

That's why we made it our mission to identify the absolute best cortisol supplements on the market in 2024. We've analyzed ...